Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 14, 2024 16:01 ET
Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer
Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, today reported financial results for the first quarter of...
May 14, 2024 16:01 ET
OptimizeRx Reports First Quarter 2024 Financial Results
OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, reported results for the three months ended...
May 14, 2024 16:01 ET
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD),...
May 14, 2024 16:01 ET
scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today...
May 14, 2024 16:01 ET
SKYX Reports Record First Quarter Sales of $19.0 Million Compared to $18.6 Million for First Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart
SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with over 90 pending and issued patents globally and over 60 lighting and home décor websites, with a mission...
May 14, 2024 16:01 ET
Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS),...
May 14, 2024 16:01 ET
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other...
May 14, 2024 16:00 ET
Arcutis Announces First Quarter 2024 Financial Results and Provides Business Update
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported financial results for the quarter ended March 31, 2024, and provided a...
May 14, 2024 16:00 ET
Beam Therapeutics to Present Data Highlighting Robust Manufacturing Process for BEAM-101 at 2024 European Hematology Association (EHA) Hybrid Congress
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will report data highlighting the robust, closed and automated manufacturing process for...
May 14, 2024 16:00 ET
CORRECTION - ES Bancshares, Inc. Announces First Quarter 2024 Results; Reports Organic Deposit Inflows, Reduces Wholesale Funding
Please note in a release issued on April 30, 2024 by ES Bancshares, that the 1Q23 data column in the Key Quarterly Financial Data table was incorrect. The amended release follows: ES Bancshares, Inc. (OTCQX: ESBS) (the “Company”) the holding...
May 14, 2024 16:00 ET
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as...
May 14, 2024 16:00 ET
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its...
May 14, 2024 16:00 ET
Oxford Lane Capital Corp. Announces Increase in Monthly Common Stock Distributions and Announces Net Asset Value and Selected Financial Results for the Fourth Fiscal Quarter
Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (“Oxford Lane,” the “Company,” “we,” “us” or “our”) announced today the following financial...
May 14, 2024 16:00 ET
TSS, Inc. Reports First Quarter 2024 Results
TSS, Inc. (Other OTC: TSSI), a data center services company that integrates high-performance computing infrastructure and software, reported results for its first quarter ended March 31, 2024. “We continued to deliver solid financial results...
May 14, 2024 15:59 ET
UPDATE: Rip Mason, Ag Resource Management’s CEO, Travels to Omaha for the 2024 Federal Reserve Agricultural Economic Summit
Today, Ag Resource Management’s (ARM) Chief Executive Officer joins U.S. agricultural credit leaders, policymakers and regulators at the Federal Reserve Bank of Kansas City’s National Economic Summit in Omaha, Nebraska. “It’s been a difficult...
May 14, 2024 15:54 ET
Jack and Dianne Stoch Transact in Shares of Globex Mining Enterprises Inc.
Jack Stoch, President, Chief Executive Officer and a director of Globex Mining Enterprises Inc. (the “Corporation”), announces that he and his wife Dianne Stoch, a director of the Corporation, acquired an aggregate of 680,000 common shares of the...
May 14, 2024 15:54 ET
SPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sprout Social, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sprout Social, Inc. (“Sprout” or “the Company”) (NASDAQ: SPT) and certain of its...
May 14, 2024 15:53 ET
Investigation Into Inotiv, Inc. (NOTV) Announced by Holzer & Holzer, LLC
Holzer & Holzer, LLC is investigating whether Inotiv, Inc. (“Inotiv” or the “Company”) (NASDAQ: NOTV) complied with federal securities laws. On May 13, 2024, Inotiv disclosed that it is unable to timely file its Quarterly Report on Form 10-Q for...
May 14, 2024 15:52 ET
Kuehn Law Encourages SQSP, HRT, RPHM, and ALE Investors to Contact Law Firm
Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. Kuehn...
May 14, 2024 15:46 ET
All Weather Windows Achieves Platinum Status for 10th Consecutive Year
All Weather Windows, a leader in high performance window and door solutions, is proud to announce its continued status as a Platinum Club member of Canada’s Best Managed Companies. Marking 16 years as a Best Managed Company, All Weather Windows is...